Skip to main content
SpringerLink
Log in

Economics a secondary consideration in serious childhood infections

  • Drug Economics and Quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hoppe JE. Rational prescribing of antibacterials in hospitalised children. Pharmacoeconomics 1996; 10(6): 575–93

    Article  PubMed  CAS  Google Scholar 

  2. Hoppe JE. Rational prescribing of antibacterials in ambulatory children. Pharmacoeconomics 1996; 10(6): 552–74

    Article  PubMed  CAS  Google Scholar 

  3. Fleisher GR, Rosenberg N, Vinci R, et al. Intramuscular versus oral antibiotic therapy for the prevention of meningitis and other bacterial sequelae in young, febrile children at risk for occult bacteremia. J Pediatr 1994; 124: 504–12

    Article  PubMed  CAS  Google Scholar 

  4. Bass JW, Steele RW, Wittler RR, et al. Antimicrobial treatment of occult bacteremia: a multicenter cooperative study. Pediatr Infect Dis J 1993; 12: 466–73

    Article  PubMed  CAS  Google Scholar 

  5. Klugman KP, Dagan R. Carbapenem treatment of meningitis. Scand J Infect Dis 1995; Suppl. 96: 45–8

    Google Scholar 

  6. O’Neill P. How long to treat bacterial meningitis. Lancet 1993; 341: 530

    Article  PubMed  Google Scholar 

  7. Powell KP, Mawhorter SD. Outpatient treatment of serious infections in infants and children with ceftriaxone. J Pediatr 1987; 110: 898–901

    Article  PubMed  CAS  Google Scholar 

  8. Lieu TA, Schwartz JS, Jaffe DM, et al. Strategies for diagnosis and treatment of children at risk for occult bacteraemia: clinical effectiveness and cost-effectiveness. J Pediatr 1991; 118: 21–9

    Article  PubMed  CAS  Google Scholar 

  9. Starke JR. Infective endocarditis. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. Philadelphia: WB Saunders, 1992: 326–43

    Google Scholar 

  10. Baltimore RS. Infective endocarditis in children. Pediatr Infect Dis J 1992; 11: 907–12

    Article  PubMed  CAS  Google Scholar 

  11. Bisno AL, Dismukes WE, Durack DT, et al. Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci and staphylococci. JAMA 1989; 261: 1471–7

    Article  PubMed  CAS  Google Scholar 

  12. Nelson JD, Bucholz RW, Kusmiesz H, et al. Benefits and risks of sequential parenteral-oral cephalosporin therapy for suppurative bone and joint infections. J Pediatr Orthop 1982; 2: 255–62

    Article  PubMed  CAS  Google Scholar 

  13. Eisenberg JM, Kitz DS. Savings from outpatient antibiotic therapy for osteomyelitis. JAMA 1986; 255: 1584–8

    Article  PubMed  CAS  Google Scholar 

  14. Schutze GE, Jacobs RF. Management of community-acquired bacterial pneumonia in hospitalized children. Pediatr Infect Dis J 1992; 11: 160–4

    Article  PubMed  CAS  Google Scholar 

  15. Gadomski AM. Potential interventions for preventing pneumonia among young children: lack of effect of antibiotic treatment for upper respiratory infections. Pediatr Infect Dis J 1993; 12: 115–20

    Article  PubMed  CAS  Google Scholar 

  16. Bahal N, Nahata MC. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin and roxithromycin. Ann Pharmacother 1992; 26: 46–55

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Economics a secondary consideration in serious childhood infections. Drugs Ther. Perspect 10, 12–16 (1997). https://doi.org/10.2165/00042310-199710060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710060-00005

Keywords

Search

Navigation